Our lab’s research focuses on understanding the metabolism and post-transcriptional regulation of advanced breast cancer as well as the molecular mechanisms by which functional foods and bioactive compounds act on chronic diseases.
We aim to answer the following:
We aim to answer the following:
- How does translation initiation orchestrate the metabolic switch in breast cancer metastasis to support cancer cell growth and proliferation?
- Can bioactive compounds restore sensitivity in breast cancer resistance to hormone therapy drugs like Tamoxifen?
NIH Funding- Our lab has successfully obtained two consecutive NIH funding awards: the SCORE award (2020-2024) and the more recent NIH SuRE R16 (2024-2028). These awards will allow us to continue our dedication to advancing cancer research and to train students from all backgrounds to become the next generation of skilled and innovative scientists.
https://app.dimensions.ai/details/grant/grant.9413475
https://reporter.nih.gov/search/bEl6AcV4i0aOP-PMdEeL9Q/project-details/10844083
https://app.dimensions.ai/details/grant/grant.9413475
https://reporter.nih.gov/search/bEl6AcV4i0aOP-PMdEeL9Q/project-details/10844083
